169 related articles for article (PubMed ID: 15983301)
1. The effect of rosiglitazone on overweight subjects with type 1 diabetes.
Strowig SM; Raskin P
Diabetes Care; 2005 Jul; 28(7):1562-7. PubMed ID: 15983301
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of rosiglitazone therapy in patients with inadequately controlled insulin-treated type 2 diabetes.
Raskin P; Rendell M; Riddle MC; Dole JF; Freed MI; Rosenstock J;
Diabetes Care; 2001 Jul; 24(7):1226-32. PubMed ID: 11423507
[TBL] [Abstract][Full Text] [Related]
3. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.
Roberts VL; Stewart J; Issa M; Lake B; Melis R
Clin Ther; 2005 Oct; 27(10):1535-47. PubMed ID: 16330290
[TBL] [Abstract][Full Text] [Related]
4. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.
Rosenstock J; Sugimoto D; Strange P; Stewart JA; Soltes-Rak E; Dailey G
Diabetes Care; 2006 Mar; 29(3):554-9. PubMed ID: 16505505
[TBL] [Abstract][Full Text] [Related]
5. Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
Derosa G; Cicero AF; D'Angelo A; Gaddi A; Ciccarelli L; Piccinni MN; Salvadeo SA; Pricolo F; Ferrari I; Gravina A; Ragonesi PD
Clin Ther; 2006 May; 28(5):679-88. PubMed ID: 16861090
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
Derosa G; Cicero AF; Gaddi AV; Ciccarelli L; Piccinni MN; Salvadeo S; Pricolo F; Fogari E; Ghelfi M; Ferrari I; Fogari R
Clin Ther; 2005 Sep; 27(9):1383-91. PubMed ID: 16291411
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study.
Patel J; Anderson RJ; Rappaport EB
Diabetes Obes Metab; 1999 May; 1(3):165-72. PubMed ID: 11220295
[TBL] [Abstract][Full Text] [Related]
8. Effect of pioglitazone therapy in lean type 1 diabetes mellitus.
Bhat R; Bhansali A; Bhadada S; Sialy R
Diabetes Res Clin Pract; 2007 Dec; 78(3):349-54. PubMed ID: 17543413
[TBL] [Abstract][Full Text] [Related]
9. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
Derosa G; Cicero AF; Gaddi A; Ragonesi PD; Fogari E; Bertone G; Ciccarelli L; Piccinni MN
Clin Ther; 2004 May; 26(5):744-54. PubMed ID: 15220018
[TBL] [Abstract][Full Text] [Related]
10. Once- and twice-daily dosing with rosiglitazone improves glycemic control in patients with type 2 diabetes.
Phillips LS; Grunberger G; Miller E; Patwardhan R; Rappaport EB; Salzman A;
Diabetes Care; 2001 Feb; 24(2):308-15. PubMed ID: 11213884
[TBL] [Abstract][Full Text] [Related]
11. Addition of nateglinide to rosiglitazone monotherapy suppresses mealtime hyperglycemia and improves overall glycemic control.
Fonseca V; Grunberger G; Gupta S; Shen S; Foley JE
Diabetes Care; 2003 Jun; 26(6):1685-90. PubMed ID: 12766094
[TBL] [Abstract][Full Text] [Related]
12. The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients.
Poulsen MK; Henriksen JE; Hother-Nielsen O; Beck-Nielsen H
Diabetes Care; 2003 Dec; 26(12):3273-9. PubMed ID: 14633813
[TBL] [Abstract][Full Text] [Related]
13. The addition of rosiglitazone to insulin in adolescents with type 1 diabetes and poor glycaemic control: a randomized-controlled trial.
Stone ML; Walker JL; Chisholm D; Craig ME; Donaghue KC; Crock P; Anderson D; Verge CF
Pediatr Diabetes; 2008 Jul; 9(4 Pt 1):326-34. PubMed ID: 18466213
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).
Zinman B; Gerich J; Buse JB; Lewin A; Schwartz S; Raskin P; Hale PM; Zdravkovic M; Blonde L;
Diabetes Care; 2009 Jul; 32(7):1224-30. PubMed ID: 19289857
[TBL] [Abstract][Full Text] [Related]
15. Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.
Derosa G; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Montagna L; Gravina A; Ferrari I; Paniga S; Cicero AF
J Clin Pharm Ther; 2006 Aug; 31(4):375-83. PubMed ID: 16882108
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes.
Gómez-Perez FJ; Fanghänel-Salmón G; Antonio Barbosa J; Montes-Villarreal J; Berry RA; Warsi G; Gould EM
Diabetes Metab Res Rev; 2002; 18(2):127-34. PubMed ID: 11994904
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological treatment of the pathogenetic defects in type 2 diabetes: the randomized multicenter South Danish Diabetes Study.
Gram J; Henriksen JE; Grodum E; Juhl H; Hansen TB; Christiansen C; Yderstræde K; Gjessing H; Hansen HM; Vestergaard V; Hangaard J; Beck-Nielsen H
Diabetes Care; 2011 Jan; 34(1):27-33. PubMed ID: 20929990
[TBL] [Abstract][Full Text] [Related]
18. Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes.
Natali A; Baldeweg S; Toschi E; Capaldo B; Barbaro D; Gastaldelli A; Yudkin JS; Ferrannini E
Diabetes Care; 2004 Jun; 27(6):1349-57. PubMed ID: 15161787
[TBL] [Abstract][Full Text] [Related]
19. Low-dose rosiglitazone in patients with insulin-requiring type 2 diabetes.
Hollander P; Yu D; Chou HS
Arch Intern Med; 2007 Jun; 167(12):1284-90. PubMed ID: 17592102
[TBL] [Abstract][Full Text] [Related]
20. Effect of Metformin Added to Insulin on Glycemic Control Among Overweight/Obese Adolescents With Type 1 Diabetes: A Randomized Clinical Trial.
Libman IM; Miller KM; DiMeglio LA; Bethin KE; Katz ML; Shah A; Simmons JH; Haller MJ; Raman S; Tamborlane WV; Coffey JK; Saenz AM; Beck RW; Nadeau KJ;
JAMA; 2015 Dec; 314(21):2241-50. PubMed ID: 26624824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
